SECsense Logo

Royalty Pharma plc 8-K Report: Key Updates and Shareholder Insights

$RPRX
Form 8-K
Filed on: 2025-02-11
Source
Royalty Pharma plc 8-K Report: Key Updates and Shareholder Insights

Based on the provided XML section of a financial report, here are the key pieces of information extracted:

  1. Entity Information:
  • Company Name: Royalty Pharma plc
  • CIK (Central Index Key): 0001802768
  • SEC File Number: 001-39329
  • EIN (Employer Identification Number): 98-1535773
  • Address: 110 East 59th Street, New York, NY 10022
  • Phone Number: (212) 883-0200
  1. Filing Type:
  • Form Type: 8-K (Current Report)
  • Filing Date: February 11, 2025
  1. Share Information:
  • Class of Shares: Class A Ordinary Shares
  • Par Value: $0.0001 per share
  • Ticker Symbol: RPRX
  • Exchange: NASDAQ
  1. Reporting Period:
  • Start Date: February 11, 2025
  • End Date: February 11, 2025

Insights:

  • The report is an 8-K filing, indicating that it is being used to disclose significant events or corporate changes that may be of interest to investors.
  • The date of the filing and the reporting period are the same, suggesting that this could be a timely disclosure related to a specific event occurring on that date.
  • The details regarding the company's shares indicate it is publicly traded, which may be relevant for investors or stakeholders analyzing stock performance and corporate actions.

This information is crucial for understanding the context of the filing, the company's identity, and the nature of the disclosed events.